A new spray-on powder developed by KAIST can stop life-threatening bleeding in about one second by instantly forming a strong gel over a wound. It works on deep and irregular injuries where ...
BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 Technologies, a Baltimore-based, minority-owned company revolutionizing emergency medical response and trauma care, has received a U.S. patent that ...
SEAL Hemostatic Wound Spray from BC3 Technologies is designed to meet the challenges of arterial bleeding. When sprayed on a wound and upon contact with blood or exudate, SEAL quickly forms a strong ...
Over 1,000 Suppliers Will Distribute Only Aerosolized Chitosan for Managing Bleeding BALTIMORE, MARYLAND, UNITED STATES, September 4, 2024 /EINPresswire / -- BC3 Technologies , a privately held ...
When sprayed on a bleeding wound, SEAL quickly forms a strong barrier that helps stop bleeding within seconds and without pain. With FDA marketing clearance, SEAL is now available by prescription and ...
(MENAFN- GlobeNewsWire - Nasdaq) -- FDA-Cleared Aerosolized Chitosan Hemostatic Agent Receives Patent for its Innovative Material and Method -- BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 ...
Baltimore, MD (3/22/2023) — BC3 Technologies, a privately held medical device company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SEAL Hemostatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results